Papers
8
Total Citations
216
H-Index
7
About
David Bock’s research centers on improving outcomes for men with localized prostate cancer, with a particular focus on comparing robot-assisted laparoscopic radical prostatectomy (RALP) to open surgery. As a key contributor to the landmark LAPPRO trial—a prospective, longitudinal multicenter study of over 4,000 patients—Bock has produced high-impact evidence on functional recovery, oncological control, and patient-reported quality of life. His most-cited work (114 citations) provides 8-year follow-up data showing comparable mortality rates between surgical techniques, while his studies on 90-day readmission (34 citations) and recurrent disease risk (10 citations) offer critical insights into postoperative care. Bock has also pioneered research into surgeon learning curves, demonstrating how experience affects outcomes, and explored the psychological dimensions of prostate cancer, including the role of negative intrusive thoughts and lifestyle factors like physical activity on long-term well-being. His work uniquely bridges objective clinical metrics with patient-reported outcomes, helping to refine surgical decision-making and postoperative support. Through the LAPPRO trial and beyond, Bock’s research continues to shape evidence-based practice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8